A venture-backed telehealth obesity medicine practice switched from a legacy EMR to Canvas, migrated their entire patient panel, and now manages high-volume GLP-1 prescribing nationwide with 34 custom plugins.
This telehealth-based obesity medicine practice pairs patients with obesity specialists and registered dietitians. Their model combines FDA-approved GLP-1 medications, nutrition therapy, and remote patient monitoring - all delivered via video, messaging, and connected medical devices.
Telehealth obesity medicine pairing patients with obesity specialists and registered dietitians. Combines FDA-approved GLP-1 medications (tirzepatide/semaglutide), nutrition therapy, and remote patient monitoring with connected medical devices. Average patient weight loss: ~13% in 6 months, up to 21% in 12 months. Multi-disciplinary care team managing full GLP-1 titration pathways.
Venture-backed by leading healthcare investors with deep operator experience. In-network with major national payers including Medicare and Medicaid, operating nationwide. Strategic healthcare operator-investor backing validates the care model at scale.
This practice switched from a legacy EMR to Canvas to get the programmability their care model demanded. GLP-1 prescribing at scale requires deep workflow customization - prior authorization automation, pharmacy API integrations, benefit verification, and RPM device data ingestion - none of which a legacy EMR could support without workarounds.
Legacy EMRs like a legacy EMR are built for general practice workflows. The company needed custom prior authorization protocols, real-time benefit verification, automated pharmacy integrations, and tight RPM device data flows - the kind of programmability that requires an open platform, not a walled garden.
Canvas gave the company a programmable EMR they could mold to their GLP-1-focused care model. Their engineering team built 34 plugins - including prior authorization automation, pharmacy API integration, benefit verification, CCM webhooks, and automated note signing - while Canvas handled scheduling, encounters, billing, and e-prescribing natively.
Migrating an active obesity medicine practice from a legacy EMR to Canvas wasn't a lift-and-shift. It was a full-scale data operation - millions of vital signs from RPM devices, complete medication histories, and years of clinical data, all mapped and validated for a new platform.
Full patient panel migrated from a legacy EMR with complete clinical history. Medication records preserving the entire prescribing timeline. Millions of vital sign records from connected RPM devices (scales, blood pressure monitors). Historical conditions, appointments, and insurance coverages. Canvas Solutions Engineering led the migration, processing records through automated migration tools.
This wasn't a typical EMR switch. Migrating an active practice with millions of RPM data points required careful data mapping, validation, and post-migration cleanup. The scale of the data - averaging 335 vitals per patient - demonstrates that Canvas can absorb enterprise-volume clinical datasets from legacy platforms without losing fidelity.
This practice runs one of the highest-volume GLP-1 prescribing operations on Canvas - managing full titration pathways, prior authorization, and pharmacy coordination at a scale that drives meaningful cost savings for payers managing obesity-related chronic disease.
The engineering team built a comprehensive plugin suite on Canvas's SDK - automating prior authorization, pharmacy coordination, benefit verification, RPM data ingestion, and clinical documentation across every step of the GLP-1 prescribing pathway.
This practice's prescribing profile and patient population reflect a highly specialized obesity medicine operation - managing complex, multi-comorbidity patients through structured GLP-1 titration pathways with insurance-backed coverage.
Tirzepatide (Mounjaro/Zepbound) dominates the prescribing profile across all dose strengths (2.5mg through 15mg), showing full titration pathway management. Semaglutide (Ozempic/Wegovy) is secondary. Phentermine complements as traditional pharmacotherapy. The dose distribution reflects long-term patient management, not one-off prescriptions.
Morbid obesity stratified by BMI class (40-44.9, 45-49.9, 50-59.9), alongside the comorbidities that drive the highest downstream healthcare costs - hypertension, hyperlipidemia, prediabetes, obstructive sleep apnea, and GERD. BMI stratification is critical for insurance authorization of GLP-1 medications, and treating the full comorbidity profile generates the largest long-term cost savings for payers.
Canvas Medical's programmable EMR gives you everything out of the box - and the SDK to build everything that makes your care model unique. Go live in weeks, not years.